Intervention

Standard medical therapy

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions5

Lead sponsors shown3

Clinical trials

3 shown

OMEGA, Local Ablative Therapy in Oligometastatic NSCLCNCT03827577 · 2019-10-01

Clopidogrel Versus Ticagrelor in Type-2 DiabetesNCT02742987 · 2014-03-01

A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart FailureNCT01311791 · 2012-08-01

Common conditions

Carcinoma, Non-Small-Cell Lung1 Coronary Artery Disease1 Diabetes Mellitus1 Dilated Cardiomyopathy1 Heart Failure1

Leading sponsors

Azienda Ospedaliera Universitaria Integrata Verona1 Campus Bio-Medico University1 LoneStar Heart, Inc.1

Trial status mix

COMPLETED2

UNKNOWN1

Phase mix

PHASE32

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.